You’re reading the web edition of STAT Health Tech, our guide to how tech is transforming the life sciences. Sign up to get this newsletter delivered in your inbox every Tuesday and Thursday.
Investigating an FDA program for medtech innovation
In a constantly-growing pool of innovative medical technologies, what does it take to be a “breakthrough”? For the last five years, the FDA’s Center for Devices and Radiological Health has applied its own definition as part of a secretive program to accelerate development and review of devices with the potential to improve care for the sickest patients. But a STAT investigation has shown that while the Breakthrough Device Program has driven significant gains for companies, its ability to drive meaningful improvements for patients is far from clear.
About the Author Reprints
Create a display name to comment
This name will appear with your comment
